PlainRecalls
FDA Devices Moderate Class II Terminated

Staclot LA 20 (REF 00594) The Staclot¿ LA and Staclot¿ LA 20 test kits are reagent systems designed for the qualitative detection of lupus anticoagulants (LA) in plasma by the use of hexagonal HII phase phospholipid molecules (1, 2).

Reported: December 26, 2018 Initiated: November 14, 2018 #Z-0611-2019

Product Description

Staclot LA 20 (REF 00594) The Staclot¿ LA and Staclot¿ LA 20 test kits are reagent systems designed for the qualitative detection of lupus anticoagulants (LA) in plasma by the use of hexagonal HII phase phospholipid molecules (1, 2).

Reason for Recall

There have been reports of shortened (T1-T2) results, where some instances of result recovery outside of the range of less than or equal to 15 seconds.

Details

Recalling Firm
Diagnostica Stago, Inc.
Units Affected
22342 total
Distribution
US Nationwide Distribution
Location
Parsippany, NJ

Frequently Asked Questions

What product was recalled?
Staclot LA 20 (REF 00594) The Staclot¿ LA and Staclot¿ LA 20 test kits are reagent systems designed for the qualitative detection of lupus anticoagulants (LA) in plasma by the use of hexagonal HII phase phospholipid molecules (1, 2).. Recalled by Diagnostica Stago, Inc.. Units affected: 22342 total.
Why was this product recalled?
There have been reports of shortened (T1-T2) results, where some instances of result recovery outside of the range of less than or equal to 15 seconds.
Which agency issued this recall?
This recall was issued by the FDA Devices on December 26, 2018. Severity: Moderate. Recall number: Z-0611-2019.